11.95
Clearpoint Neuro Inc Aktie (CLPT) Neueste Nachrichten
How to Take Advantage of moves in (CLPT) - news.stocktradersdaily.com
Vanguard Group Inc. Purchases 5,400 Shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
Head to Head Analysis: ClearPoint Neuro (NASDAQ:CLPT) vs. Avinger (NASDAQ:AVGR) - Defense World
Financial Analysis: ClearPoint Neuro (NASDAQ:CLPT) vs. enVVeno Medical (NASDAQ:NVNO) - Defense World
ClearPoint Neuro (NASDAQ:CLPT) Given New $25.00 Price Target at Stifel Nicolaus - Defense World
Stifel raises Clearpoint Neuro stock target to $25 on growth potential - Investing.com Canada
Here's Why We're Not Too Worried About ClearPoint Neuro's (NASDAQ:CLPT) Cash Burn Situation - Yahoo
Both individual investors who control a good portion of ClearPoint Neuro, Inc. (NASDAQ:CLPT) along with institutions must be dismayed after last week's 11% decrease - simplywall.st
ClearPoint Neuro Inc (CLPT) Shares Gap Down to $13.235 on Mar 25 - GuruFocus.com
When (CLPT) Moves Investors should Listen - news.stocktradersdaily.com
Connor Clark & Lunn Investment Management Ltd. Reduces Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
ClearPoint Neuro (CLPT) to Release Quarterly Earnings on Tuesday - Defense World
MRI Interventions, Inc. Announces 2016 Fourth Quarter and Full Year Results - ACCESS Newswire
How To Trade (CLPT) - Stock Traders Daily
What is B. Riley’s Forecast for CLPT FY2025 Earnings? - Defense World
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Analysts Are Pretty Bullish On The Stock After Recent Results - Yahoo Finance
Taylor Frigon Capital Management LLC Sells 162,551 Shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
ClearPoint Neuro: Drug Delivery Prospects Continue To Strengthen - Seeking Alpha
ClearPoint Neuro’s Earnings Call Highlights Robust Growth - TipRanks
MRI Interventions, Inc. Announces 2016 Third Quarter and Nine Month Results - ACCESS Newswire
ClearPoint Neuro (NASDAQ:CLPT) Issues Earnings Results, Misses Estimates By $0.05 EPS - MarketBeat
ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Misses Revenue Estimates - MSN
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q4 2024 Earnings Call Transcript - Insider Monkey
ClearPoint Neuro Achieves Record Growth in 2024 - TipRanks
Clearpoint Neuro Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: ClearPoint Neuro Q4 2024 sees stock dip post-earnings - Investing.com India
ClearPoint Neuro Reports Record 2024 Revenue Growth - TipRanks
ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results - ACCESS Newswire
ClearPoint Neuro Crushes Expectations With 76% Product Revenue Surge in Latest Earnings - StockTitan
ClearPoint Neuro Inc (CLPT) Q4 2024: Everything You Need To Know Ahead Of Earnings - GuruFocus.com
Clearpoint Neuro Inc expected to post a loss of 16 cents a shareEarnings Preview - TradingView
ClearPoint Neuro (CLPT) Projected to Post Earnings on Wednesday - Defense World
(CLPT) Trading Report - Stock Traders Daily
The Power Shift: How Small Investors Rule ClearPoint Neuro - Elblog.pl
Power to the People: How Individual Investors Are Influencing ClearPoint Neuro - Zaman
While institutions own 33% of ClearPoint Neuro, Inc. (NASDAQ:CLPT), individual investors are its largest shareholders with 59% ownership - Yahoo Finance
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Short Interest Down 22.1% in January - MarketBeat
Solventum (NYSE:SOLV) and ClearPoint Neuro (NASDAQ:CLPT) Head-To-Head Review - Defense World
What Do Wall Street Analysts Think About ClearPoint Neuro Inc (NASDAQ: CLPT) Stock? - Stocks Register
Legato Capital Management LLC Lowers Stock Holdings in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
After Leaping 25% ClearPoint Neuro, Inc. (NASDAQ:CLPT) Shares Are Not Flying Under The Radar - Simply Wall St
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025 - ACCESS Newswire
ClearPoint Neuro Sets Stage for Crucial 2024 Financial Review: What the Brain Tech Leader Will Reveal - StockTitan
ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula - WICZ
Game-Changing Brain Drug Delivery Device Gets Major EU Regulatory Win - StockTitan
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):